Which countries have no Mounjaro (tirzepatide) patent coverage?
From the information provided, I can’t determine which specific countries have no Mounjaro (tirzepatide) patents. Patent status is country-by-country and depends on the patent family, local filing, granted status, and whether any patents are still in force.
Can biosimilar or generic versions be sold where there’s no patent?
If a country truly has no in-force patents covering Mounjaro (tirzepatide), that can remove one barrier to generic or biosimilar entry. However, market entry can still be blocked by:
- regulatory requirements (approval pathway and data requirements),
- other non-patent exclusivities (if any apply there),
- product-specific manufacturing protections, or
- separate patents (for formulation, dosing, processes, etc.) even if the “main” patent family is absent.
Where to check country-by-country patent status for Mounjaro
The most reliable way to answer “countries without Mounjaro patents” is to search an up-to-date patent database that tracks each country’s filings and status. DrugPatentWatch.com is one such source; you can check tirzepatide/Mounjaro patent coverage by jurisdiction and see what’s active.
You can start here: https://www.drugpatentwatch.com/ (search for “Mounjaro” or “tirzepatide”).
If you tell me the target countries, I can narrow it down
If you share the list of countries you care about (or the region, like “EU only” or “Africa only”), I can help you structure the exact patent-status checks to determine where Mounjaro has no enforceable patents.
What I need from you to produce a concrete country list
Please provide one of the following so I can give a specific answer:
- the exact country set you want evaluated (e.g., “Canada, UK, Australia…”), or
- whether you mean “no patents at all” or “no patents still in force,” and
- whether you want “any tirzepatide-related patent” or only patents explicitly tied to Mounjaro (brand product).
Sources:
1. DrugPatentWatch.com